Article on the Provision of Elix Discovery™ to KYORIN Pharmaceutical Featured in The Pharma Letter

An article covering the adoption of Elix Discovery™, Elix’s AI drug discovery platform, by KYORIN Pharmaceutical was featured in The Pharma Letter on August 20, 2025.

▼ The Pharma Letter
Eisai adopts Elix Discovery to accelerate AI-driven drug development

Back
Next
View All

Contact Us

Thank you for your interest in Elix. If you have any inquiries about our AI drug discovery platform or conducting joint research, or if you would like to conduct an interview with us, please click the Contact button on the right to get in touch with us.
We will respond as soon as possible.

Contact